Home
About Us
Core Team
Development History
Corporate Culture
S&T
Research Areas
Technology Platforms
Research and Development
Marketed Products
R&D Products
R&D Pipeline
Academic Progress
Blog
Company News
Media Reports
Join Us
Post-Doctoral Center
Contact Us
[Case Share] Issue 79: Nivolumab Treatment for Triple-Negative Breast Cancer
View details
→
[Case Share] Issue 78: A Case Report on Nilotinib Treatment for Recurrent and Metastatic Nasopharyngeal Carcinoma
[Case Share] Issue 77: Nivolumab Treatment for Advanced, Large-Sized Facial Squamous Cell Carcinoma
[Case Share] Issue 76: Nilotinib Treatment for Undifferentiated Nasopharyngeal Carcinoma
[Case Share] Issue 75: Case Study on Nivolumab Combination Therapy Combined with Concurrent Chemoradiotherapy for Advanced Esophageal Squamous Cell Carcinoma
[Case Share] Issue 74: Induction Chemotherapy and Concurrent Chemo-Radiotherapy Combined with Nimotuzumab for Locally Advanced Nasopharyngeal Carcinoma